4AB:FRA
AbbVie Common Stock
233,10 €
arrow_upward
+1,30%(+3,00) 1D
2 қаз., 13:05:33 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
230,00 €
High
233,10 €
Low
230,00 €
Mkt. cap
461,18 млрд
Avg. vol.
47,00
Volume
5,00
52-wk high
235,70 €
52-wk low
167,55 €
No. of employees
57 мың
Open
230,00 €
High
233,10 €
Low
230,00 €
Mkt. cap
461,18 млрд
Avg. vol.
47,00
Volume
5,00
52-wk high
235,70 €
52-wk low
167,55 €
No. of employees
57 мың
News stories
From web sources and news partners
Yahoo Finance
·
2 сағат бұрын
Can ABBV's New Parkinson's Pill Strengthen Its Neuroscience Franchise?
AD HOC NEWS
·
3 сағат бұрын
AbbVie wins FDA approval for Juvmo. AbbVie stock sits 3.48 percent below its 52-week high
The Globe and Mail
·
4 сағат бұрын
AbbVie (ABBV) Receives a Buy from Scotiabank
The Motley Fool
·
16 сағат бұрын
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 мың
Founded2012 ж. 10 сәу.
HeadquartersNorth Chicago, Иллинойс, Америка Құрама Штаттары
Sector-
Websiteabbvie.com